GB8500121D0 - Microencapsulation of living cells - Google Patents

Microencapsulation of living cells

Info

Publication number
GB8500121D0
GB8500121D0 GB858500121A GB8500121A GB8500121D0 GB 8500121 D0 GB8500121 D0 GB 8500121D0 GB 858500121 A GB858500121 A GB 858500121A GB 8500121 A GB8500121 A GB 8500121A GB 8500121 D0 GB8500121 D0 GB 8500121D0
Authority
GB
United Kingdom
Prior art keywords
cellular material
polymer
polyanionic
polycationic
microencapsulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858500121A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Priority to GB858500121A priority Critical patent/GB8500121D0/en
Publication of GB8500121D0 publication Critical patent/GB8500121D0/en
Priority to CA000498218A priority patent/CA1258429A/en
Priority to DE8686300021T priority patent/DE3671368D1/de
Priority to EP86300021A priority patent/EP0188309B1/en
Priority to AT86300021T priority patent/ATE52913T1/de
Priority to JP61000136A priority patent/JPS61209586A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/022Artificial gland structures using bioreactors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
GB858500121A 1985-01-03 1985-01-03 Microencapsulation of living cells Pending GB8500121D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB858500121A GB8500121D0 (en) 1985-01-03 1985-01-03 Microencapsulation of living cells
CA000498218A CA1258429A (en) 1985-01-03 1985-12-20 Microencapsulation of living cells
DE8686300021T DE3671368D1 (de) 1985-01-03 1986-01-03 Mikroeinkapsulierung lebender zellen.
EP86300021A EP0188309B1 (en) 1985-01-03 1986-01-03 Microencapsulation of living cells
AT86300021T ATE52913T1 (de) 1985-01-03 1986-01-03 Mikroeinkapsulierung lebender zellen.
JP61000136A JPS61209586A (ja) 1985-01-03 1986-01-04 生細胞マイクロカプセル及びその形成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858500121A GB8500121D0 (en) 1985-01-03 1985-01-03 Microencapsulation of living cells

Publications (1)

Publication Number Publication Date
GB8500121D0 true GB8500121D0 (en) 1985-02-13

Family

ID=10572378

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858500121A Pending GB8500121D0 (en) 1985-01-03 1985-01-03 Microencapsulation of living cells

Country Status (6)

Country Link
EP (1) EP0188309B1 (cg-RX-API-DMAC7.html)
JP (1) JPS61209586A (cg-RX-API-DMAC7.html)
AT (1) ATE52913T1 (cg-RX-API-DMAC7.html)
CA (1) CA1258429A (cg-RX-API-DMAC7.html)
DE (1) DE3671368D1 (cg-RX-API-DMAC7.html)
GB (1) GB8500121D0 (cg-RX-API-DMAC7.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3575375D1 (de) * 1984-02-15 1990-02-22 Massachusetts Inst Technology Verfahren zur verkapselung und systeme mit verkapseltem aktivmaterial.
NO166836C (no) * 1985-03-14 1991-09-11 Univ California Fremgangsmaate for behandling av et organtransplantat.
DE3871176D1 (de) * 1987-02-25 1992-06-25 Hoechst Ag Mikroenkapsulierung von biologisch aktivem material.
DE3870061D1 (de) * 1987-06-19 1992-05-21 Univ Temple Mikrokapseln mit gelenkter freigabe und verfahren zu deren herstellung.
EP0301777A1 (en) * 1987-07-28 1989-02-01 Queen's University At Kingston Multiple membrane microencapsulation
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5418154A (en) * 1987-11-17 1995-05-23 Brown University Research Foundation Method of preparing elongated seamless capsules containing biological material
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5201778A (en) * 1989-07-04 1993-04-13 Giovanni Brotzu Vascular prosthesis containing in the wall microcapsules, including hormone-producing cells
ATE131042T1 (de) * 1990-04-25 1995-12-15 Hoechst Ag Pharmakologische zubereitung, enthaltend polyelektrolytkomplexe in mikropartikulärer form und mindestens einen wirkstoff.
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5733336A (en) * 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
JP3508023B2 (ja) * 1990-10-31 2004-03-22 バクスター、インターナショナル、インコーポレイテッド 密接血管化埋め込み材料
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
ES2107537T3 (es) * 1991-04-25 1997-12-01 Univ Brown Res Found Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados.
US5800829A (en) * 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
US5232712A (en) * 1991-06-28 1993-08-03 Brown University Research Foundation Extrusion apparatus and systems
US6773458B1 (en) 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
EP0655910A4 (en) * 1992-07-29 1996-02-28 Univ Washington USE OF A BAG FOR IMPLANTING LIVING CELLS.
FR2696658B1 (fr) * 1992-10-14 1994-11-18 Hospal Ind Procédé et dispositif d'encapsulation d'une substance, ainsi que capsule obtenue.
AU6243294A (en) * 1993-02-18 1994-09-14 New England Deaconess Hospital Corporation Implantable artificial organ
DE4312970A1 (de) * 1993-04-21 1994-10-27 Juergen Dr Schrezenmeir Mikrokapsel sowie Verfahren und Vorrichtung zu ihrer Herstellung
AU688776B2 (en) * 1993-06-23 1998-03-19 Brown University Research Foundation Method and apparatus for sealing implantable, membrane encapsulation devices
US5908623A (en) 1993-08-12 1999-06-01 Cytotherapeutics, Inc. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
EP1179350A3 (en) * 1993-08-12 2003-01-02 Cytotherapeutics, Inc. Encapsulated cell system for implantation into the human CNS
WO1995008355A1 (en) * 1993-09-24 1995-03-30 Baxter International Inc. Methods for enhancing vascularization of implant devices
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US6156305A (en) * 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
DE4426396A1 (de) * 1994-07-26 1996-02-01 Ulrich Prof Dr Zimmermann Verfahren zur Herstellung konzentrierter Lösungen von mikroverkapselten Zellen oder von suspendierten Wirkstoffen in mikroverkapselter Form
US5674495A (en) * 1995-02-27 1997-10-07 Purdue Research Foundation Alginate-based vaccine compositions
EP0747046A3 (en) * 1995-05-19 1997-12-03 Baxter International Inc. Permeable immunoisolation membrane structures for implantation of cells in host tissue
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
WO2001087270A2 (en) 2000-05-12 2001-11-22 Pharmacia & Upjohn Company Vaccine composition, method of preparing the same, and method of vaccinating vertebrates
AU2002310567B2 (en) 2001-05-30 2005-10-20 Csir Method of encapsulating an active substance
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
PL405101A1 (pl) 2013-08-20 2015-03-02 Zachodniopomorski Uniwersytet Technologiczny W Szczecinie Sposób wytwarzania mikrokapsułek

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
NO158284C (no) * 1981-03-13 1988-08-17 Damon Biotech Inc Fremgangsmaate for selektiv oppbrytning av en permeabel membran.

Also Published As

Publication number Publication date
EP0188309A3 (en) 1987-09-02
JPS61209586A (ja) 1986-09-17
DE3671368D1 (de) 1990-06-28
EP0188309B1 (en) 1990-05-23
EP0188309A2 (en) 1986-07-23
CA1258429A (en) 1989-08-15
JPH0534946B2 (cg-RX-API-DMAC7.html) 1993-05-25
ATE52913T1 (de) 1990-06-15

Similar Documents

Publication Publication Date Title
EP0188309A3 (en) Microencapsulation of living cells
DE3380788D1 (en) Microencapsulation of living tissue and cells
EP0248531A3 (en) Encapsulated nucleic acids
ES2075148T3 (es) Acido alfa-glicosil-l-ascorbico, y su preparacion y usos.
EP0392813A3 (en) Processes for reconstituting lyophilized erythrocytes and/or hemosomes
IL94722A0 (en) Media for cell growth and their production
PT83746B (pt) Processo para a preparacao de novos biocatalisadores imobilizados e para a producao de etanol por fermentacao
EP0342879A3 (en) Lyophilization of erythrocytes and media for use therein
EP0374625A3 (en) Viral inactivation process
GB1516704A (en) Glucose isomerase
ES8202043A1 (es) Procedimiento para la preparacion de copolimeros de polisa- caridos portadores de actividad enzimatica
DE3686702D1 (de) Biologisch aktive topische kollagentraegermatrix: kosmetische und pharmazeutische verwendung und verfahren zu deren herstellung.
Tomašić et al. Peptidoglycan monomer originating from Brevibacterium divaricatum-its metabolism and biological activities in the host
EP0278556A3 (en) Spherical biocatalyst and process for its preparation
DK313288D0 (da) Fremgangsmaade til fremstilling af immobiliseret enzym
ATE94906T1 (de) Verfahren zur herstellung von l-alphaaminos|uren.
JPS5583710A (en) Spongy enzyme preparation
ES8702463A1 (es) Un procedimiento para preparar un material polimero hidrofilo basado en polisacaridos polipeptidos y -o proteinas y derivados acrilicos hidrofilos.
EP0085573A3 (en) Interfacial growth of cells in tissue culture
EP0314042A3 (en) Novel copolymers and superoxide dismutase modified with said copolymers
JPS54110385A (en) Immobilization of enzyme
Tyurin et al. Some peculiarities of the ultrathin structure of Methylococcus capsulatus cells cultivated under different conditions.
Falb Review of recent enzyme immobilization techniques
JPS5743687A (en) Immobilized enzymic composition
JPS57132883A (en) Preparation of immobilized enzymically active substance